|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2001-4-5
|
|
pubmed:abstractText |
We have previously presented a technique that fuses ProstaScint and pelvic CT images for the purpose of designing brachytherapy that targets areas at high risk for treatment failure. We now correlate areas of increased intensity seen on ProstaScint-CT fusion images to biopsy results in a series of 7 patients to evaluate the accuracy of this technique in localizing intraprostatic disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1281-6
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11286835-Adenocarcinoma,
pubmed-meshheading:11286835-Antibodies, Monoclonal,
pubmed-meshheading:11286835-Biopsy,
pubmed-meshheading:11286835-Humans,
pubmed-meshheading:11286835-Indium Radioisotopes,
pubmed-meshheading:11286835-Male,
pubmed-meshheading:11286835-Prospective Studies,
pubmed-meshheading:11286835-Prostate,
pubmed-meshheading:11286835-Prostatic Neoplasms,
pubmed-meshheading:11286835-Radioimmunodetection,
pubmed-meshheading:11286835-Sensitivity and Specificity,
pubmed-meshheading:11286835-Tomography, X-Ray Computed
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Radioimmunoguided imaging of prostate cancer foci with histopathological correlation.
|
|
pubmed:affiliation |
Department of Radiation Oncology, University Hospitals of Cleveland, Cleveland, OH 44106, USA. rod.ellis@uhhs.com
|
|
pubmed:publicationType |
Journal Article
|
